Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study
<b>(1) Background:</b> Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders involving innate and adaptive immune responses. Despite primarily affecting the gut, recent insights highlight systemic implications, expanding our understanding beyond intestinal boundaries. <...
Main Authors: | Marta Vernero, Simone Saibeni, Davide Scalvini, Carolina Cicalini, Lorenzo Chiarello, Silvia Nardi, Davide Giuseppe Ribaldone, Cristina Bezzio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/4/1019 |
Similar Items
-
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey
by: Marta Vernero, et al.
Published: (2024-03-01) -
Dermatological changes associated with non-specific inflammatory bowel diseases – Crohn’s disease and ulcerative colitis
by: Agnieszka Hołdrowicz, et al.
Published: (2020-10-01) -
Quality of life in inflammatory bowel diseases: it is not all about the bowel
by: Ronald Keller, et al.
Published: (2021-01-01) -
Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease
by: Marta Vernero, et al.
Published: (2023-10-01) -
Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease
by: Istvan Fedor, et al.
Published: (2021-12-01)